Rigvir

subcutaneous

RIGVIR is a virus therapy that has been promoted to treat melanoma.

The drug consists of live viruses that cannot cause disease. According to the manufacturer, the viruses specifically infect tumor cells and lead to their death.

RIGVIR was approved in Latvia for the treatment of melanoma. The approval has been withdrawn recently.

I do not recommend RIGVIR because there has been controversy about the quality of the product in the past.

en_USEnglish